NasdaqCM - Delayed Quote
USD
XTL Biopharmaceuticals Ltd. (XTLB)
1.5301
-0.0199
(-1.28%)
At close: November 9 at 4:00:00 PM EST
Loading chart for XTLB
Chart does not reflect overnight price.
- Previous Close
1.5500 - Open
1.5500 - Bid 1.6600 x 200
- Ask 2.2700 x 1000
- Day's Range
1.5200 - 2.0999 - 52 Week Range
1.5200 - 5.6400 - Volume
17,309 - Avg. Volume
8,282 - Market Cap (intraday)
3.76M - Beta (5Y Monthly) 0.47
- PE Ratio (TTM)
-- - EPS (TTM)
-0.3600 - Earnings Date --
- Forward Dividend & Yield -- (0.00%)
- 1y Target Est
-- - Moby Rating Neutral
Recent News
View MorePerformance Overview
Trailing total returns as of 11/9/2026, which may include dividends or other distributions. Benchmark is TA-125 (^TA125.TA) .
YTD Return
XTLB
45.35%
TA-125 (^TA125.TA)
6.68%
1-Year Return
XTLB
61.75%
TA-125 (^TA125.TA)
0.00%
3-Year Return
XTLB
55.00%
TA-125 (^TA125.TA)
126.30%
5-Year Return
XTLB
90.12%
TA-125 (^TA125.TA)
96.96%
Earnings Trends
View MoreStatistics
View MoreValuation Measures
-
Market Cap
-
Enterprise Value
-
Trailing P/E
-
Forward P/E
-
PEG Ratio (current)
-
Price/Sales (ttm)
-
Price/Book (mrq)
-
Enterprise Value/Revenue
-
Enterprise Value/EBITDA
Financial Highlights
Profitability and Income Statement
-
Profit Margin
0.00%
-
Return on Assets (ttm)
-21.01%
-
Return on Equity (ttm)
-29.30%
-
Revenue (ttm)
--
-
Net Income Avi to Common (ttm)
-759k
-
Diluted EPS (ttm)
-0.3600
Balance Sheet and Cash Flow
-
Total Cash (mrq)
76k
-
Total Debt/Equity (mrq)
--
-
Levered Free Cash Flow (ttm)
-2.12M
